Trade Summary

3 days ago, Rosett Max, serving as Chief Financial Officer at Immunome Inc. (IMNM), sold 60,000 shares at $18.23 per share, for a total transaction value of $1,093,800.00. Following this transaction, Rosett Max now holds 54,037 shares of IMNM.

This sale represents a 52.61% decrease in Rosett Max's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 5:26 PM ET, 2 days after the trade was made.

Immunome Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.